BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  GrowBLOX Sciences, Inc. Names Chief Science Officer And Member Of The Board Of Directors

  June 16, 2014

   · 

  3 min read
• Pharm Country

  Advances In Predictive Hypoglycemia-Minimizing Technology From Animas Corporation-JDRF Collaboration At American Diabetes Association Scientific Sessions

  June 16, 2014

   · 

  6 min read
• BioMidwest

  UC Charting Solutions’ EHR Software, ProMentum, Attains 2014 ONC-ACB Certification

  June 16, 2014

   · 

  4 min read
• Drug Development

  Intarcia Therapeutics, Inc. Presents Interim Phase 3 Data At American Diabetes Association Showing ITCA 650, A Once Yearly GLP-1, Markedly Reduces Blood Sugar In Patients With Very Poorly Controlled Diabetes

  June 16, 2014

   · 

  7 min read
• Pharm Country

  Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction

  June 16, 2014

   · 

  4 min read
• Biotech Bay

  Cepheid Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria

  June 16, 2014

   · 

  6 min read
• Biotech Beach

  Protein Metrics Announces Release Of Preview™ Software As Freeware To The Proteomics And Biopharmaceutical Communities

  June 16, 2014

   · 

  2 min read
• Business

  TrovaGene, Inc. Announces Clinical Collaboration With Dana-Farber Cancer Institute

  June 16, 2014

   · 

  4 min read
• BioForest

  Acumed® Introduces New Solution To Help Treat Post-Traumatic Arthritis: Total Wrist Fusion Plating System

  June 16, 2014

   · 

  4 min read
• Drug Development

  Karyopharm Therapeutics Announces: FDA Considers The Effectiveness And Safety Technical Sections Complete To Support Conditional Approval For The New Animal Drug Application For Verdinexor (KPT-335) To Treat Lymphoma In Client Owned Dogs

  June 16, 2014

   · 

  1 min read